These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17702861)

  • 1. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation.
    Tai X; Van Laethem F; Sharpe AH; Singer A
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13756-61. PubMed ID: 17702861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.
    Tai X; Cowan M; Feigenbaum L; Singer A
    Nat Immunol; 2005 Feb; 6(2):152-62. PubMed ID: 15640801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
    Marengère LE; Okkenhaug K; Clavreul A; Couez D; Gibson S; Mills GB; Mak TW; Rottapel R
    J Immunol; 1997 Oct; 159(7):3220-9. PubMed ID: 9317120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation requirements of induced murine systemic autoimmune disease.
    Pollard KM; Arnush M; Hultman P; Kono DH
    J Immunol; 2004 Nov; 173(9):5880-7. PubMed ID: 15494542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
    Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
    J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B70 antigen is a second ligand for CTLA-4 and CD28.
    Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
    Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.
    Schneider H; Martin M; Agarraberes FA; Yin L; Rapoport I; Kirchhausen T; Rudd CE
    J Immunol; 1999 Aug; 163(4):1868-79. PubMed ID: 10438921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
    Burr JS; Kimzey SL; Randolph DR; Green JM
    Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.
    Matsui T; Kurokawa M; Kobata T; Oki S; Azuma M; Tohma S; Inoue T; Yamamoto K; Nishioka K; Kato T
    J Immunol; 1999 Apr; 162(7):4328-35. PubMed ID: 10201965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 signaling in primary CD4(+) T cells: identification of both tyrosine phosphorylation-dependent and phosphorylation-independent pathways.
    Ogawa S; Watanabe M; Sakurai Y; Inutake Y; Watanabe S; Tai X; Abe R
    Int Immunol; 2013 Dec; 25(12):671-81. PubMed ID: 24048955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
    J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.
    Friend LD; Shah DD; Deppong C; Lin J; Bricker TL; Juehne TI; Rose CM; Green JM
    J Exp Med; 2006 Sep; 203(9):2121-33. PubMed ID: 16908623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.